Cargando…

1766P COVID-19 and lung cancer: What do we know?

Detalles Bibliográficos
Autores principales:	Serrano, G., Rogado, J., Pangua, C., Obispo, B., Martin Marino, A., Perez-Perez, M., Lopez-Alfonso, A., Lara, M.A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Society for Medical Oncology. Published by Elsevier Ltd. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506331/ http://dx.doi.org/10.1016/j.annonc.2020.08.1830

Ejemplares similares

1771P Do breast cancer patients with COVID-19 have a poor prognosis? Experience in a hospital in Madrid
por: Obispo, B., et al.
Publicado: (2020)

1685P Is cancer what determines COVID-19 oncological patient’s outcome or are other external factors involved? Experience in a hospital in Madrid, Spain
por: Rogado, J., et al.
Publicado: (2020)

1573P First wave mortality data versus full pandemic period from the COVID-CANCER HUIL study
por: Serrano-Montero, G., et al.
Publicado: (2021)

1576P COVID-CANCER HUIL - Registry of oncological patients with diagnosis of COVID-19 at Hospital Universitario Infanta Leonor in Madrid (Spain): One year of pandemic
por: Rogado, J., et al.
Publicado: (2021)

Covid-19 and lung cancer: A greater fatality rate?
por: Rogado, Jacobo, et al.
Publicado: (2020)

Covid-19 transmission, outcome and associated risk factors in cancer patients at the first month of the pandemic in a Spanish hospital in Madrid
por: Rogado, J., et al.
Publicado: (2020)

Lung emphysema and lung cancer: what do we know about it?
por: Tubío-Pérez, Ramón A., et al.
Publicado: (2020)

COVID-19 mortality in cancer patients in a Madrid hospital during the first 3 weeks of the epidemic()
por: Lara Álvarez, Miguel Ángel, et al.
Publicado: (2020)

Mortalidad por COVID-19 en pacientes con cáncer en un hospital de Madrid durante las primeras 3 semanas de epidemia
por: Lara Álvarez, Miguel Ángel, et al.
Publicado: (2020)

Prevalence of thrombosis in patients with cancer and SARS-CoV-2 infection
por: Obispo, Berta, et al.
Publicado: (2022)

Prevalence of thrombosis in patients with cancer and SARS-CoV-2 infection
por: Obispo, Berta, et al.
Publicado: (2022)

Quasicrystals: What do we know? What do we want to know? What can we know?
por: Steurer, Walter
Publicado: (2018)

What do we know and when do we know it?
por: Nicholls, Anthony
Publicado: (2008)

Presbyopia: What We Do Know and What We Do Not Know in 2022
por: Grzybowski, Andrzej, et al.
Publicado: (2023)

Transmission of Ebola Viruses: What We Know and What We Do Not Know
por: Osterholm, Michael T., et al.
Publicado: (2015)

Vaginal Aging—What We Know and What We Do Not Know
por: Szymański, Jacek K., et al.
Publicado: (2021)

Cerebrospinal fluid circulation: What do we know and how do we know it?
por: Khasawneh, Ahmad H, et al.
Publicado: (2018)

Metal wear particles: What we know, what we do not know, and why
por: Billi, Fabrizio, et al.
Publicado: (2009)

Cardiac surgery and the coronavirus disease 2019 pandemic: What we know, what we do not know, and what we need to do
por: Bakaeen, Faisal G., et al.
Publicado: (2020)

Mechanisms of atrial fibrillation in athletes: what we know and what we do not know
por: Guasch, E., et al.
Publicado: (2018)

Management of T1 Urothelial Carcinoma of the Bladder: What Do We Know and What Do We Need To Know?
por: Gershman, Boris, et al.
Publicado: (2015)

The postictal state — What do we know?
por: Pottkämper, Julia C. M., et al.
Publicado: (2020)

Estrogens in schizophrenia: What do we know?
por: Ferreira, L. Paulino, et al.
Publicado: (2021)

Multimorbidity: What do we know? What should we do?
por: Navickas, Rokas, et al.
Publicado: (2016)

Characteristics and outcome of lung cancer patients and Covid-19 infection in a second-level hospital during the first 3 months of the pandemic()
por: Rogado, Jacobo, et al.
Publicado: (2020)

Sodium and brain injury: do we know what we are doing?
por: Zygun, David A
Publicado: (2009)

Thymic neuroendocrine neoplasms—what we know, what we don’t know, and what to do about it
por: Lang, Matthias, et al.
Publicado: (2023)

Microbiome in Multiple Sclerosis: Where Are We, What We Know and Do Not Know
por: Boziki, Marina Kleopatra, et al.
Publicado: (2020)

Biogenic Silver Nanoparticles: What We Know and What Do We Need to Know?
por: Rai, Mahendra, et al.
Publicado: (2021)

Ticks and Tularemia: Do We Know What We Don't Know?
por: Zellner, Briana, et al.
Publicado: (2019)

The risk of viral transmission in feed: What do we know, what do we do?
por: Dee, Scott A., et al.
Publicado: (2020)

Experimental subjects do not know what we think they know
por: Field, Jared M., et al.
Publicado: (2020)

New potential targeted strategies in small cell lung cancer
por: de Toro, María, et al.
Publicado: (2023)

Relic gravitons from the pre-big bang: what we know and what we do not know
por: Gasperini, M.
Publicado: (1996)

P-glycoprotein and cancer: what do we currently know?
por: Pilotto Heming, Carlos, et al.
Publicado: (2022)

Neuropathic pain; what we know and what we should do about it
por: Smith, Peter A.
Publicado: (2023)

Management of lung disease in alpha-1 antitrypsin deficiency: what we do and what we do not know
por: Barjaktarevic, Igor, et al.
Publicado: (2021)

Mean Age of First Sex: Do They Know What We Mean?
por: de Irala, Jokin, et al.
Publicado: (2011)

Do Our Colleagues Accurately Know What We Do?
por: Mrad, Mohamed Amir, et al.
Publicado: (2022)

Role of the Eye in Transmitting Human Coronavirus: What We Know and What We Do Not Know
por: Sun, Chuan-bin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sbqd4s5r0ag52klfla7k22pcg1